BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17376828)

  • 1. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes.
    Tracy S; Drescher KM
    Ann N Y Acad Sci; 2007 Apr; 1103():143-51. PubMed ID: 17376828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection.
    Drescher KM; Kono K; Bopegamage S; Carson SD; Tracy S
    Virology; 2004 Nov; 329(2):381-94. PubMed ID: 15518817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.
    Tracy S; Drescher KM; Chapman NM; Kim KS; Carson SD; Pirruccello S; Lane PH; Romero JR; Leser JS
    J Virol; 2002 Dec; 76(23):12097-111. PubMed ID: 12414951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency.
    Kanno T; Kim K; Kono K; Drescher KM; Chapman NM; Tracy S
    J Virol; 2006 Jun; 80(11):5637-43. PubMed ID: 16699045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coxsackievirus immunization delays onset of diabetes in non-obese diabetic mice.
    Davydova B; Härkönen T; Kaialainen S; Hovi T; Vaarala O; Roivainen M
    J Med Virol; 2003 Apr; 69(4):510-20. PubMed ID: 12601759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T-cells protect from type 1 diabetes after induction by coxsackievirus infection in the context of transforming growth factor-beta.
    Richer MJ; Straka N; Fang D; Shanina I; Horwitz MS
    Diabetes; 2008 May; 57(5):1302-11. PubMed ID: 18268045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coxsackievirus B4 and type 1 diabetes pathogenesis: contribution of animal models.
    Jaïdane H; Sané F; Gharbi J; Aouni M; Romond MB; Hober D
    Diabetes Metab Res Rev; 2009 Oct; 25(7):591-603. PubMed ID: 19621354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Group B coxsackieviruses and autoimmunity: focus on Type 1 diabetes.
    Sané F; Moumna I; Hober D
    Expert Rev Clin Immunol; 2011 May; 7(3):357-66. PubMed ID: 21595602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirements for viral-mediated autoimmune diabetes: beta-cell damage and immune infiltration.
    Horwitz MS; Fine C; Ilic A; Sarvetnick N
    J Autoimmun; 2001 May; 16(3):211-7. PubMed ID: 11334485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
    Serreze DV; Marron MP; Dilorenzo TP
    Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes.
    Jaïdane H; Hober D
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):537-48. PubMed ID: 18951821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral infections as potential triggers of type 1 diabetes.
    van der Werf N; Kroese FG; Rozing J; Hillebrands JL
    Diabetes Metab Res Rev; 2007 Mar; 23(3):169-83. PubMed ID: 17103489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coxsackieviral-mediated diabetes: induction requires antigen-presenting cells and is accompanied by phagocytosis of beta cells.
    Horwitz MS; Ilic A; Fine C; Balasa B; Sarvetnick N
    Clin Immunol; 2004 Feb; 110(2):134-44. PubMed ID: 15003810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coxsackievirus can persist in murine pancreas by deletion of 5' terminal genomic sequences.
    Tracy S; Smithee S; Alhazmi A; Chapman N
    J Med Virol; 2015 Feb; 87(2):240-7. PubMed ID: 25111164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on isolated human pancreatic islet cells after infection with strains of enterovirus isolated at clinical presentation of type 1 diabetes.
    Elshebani A; Olsson A; Westman J; Tuvemo T; Korsgren O; Frisk G
    Virus Res; 2007 Mar; 124(1-2):193-203. PubMed ID: 17169456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferons induce an antiviral state in human pancreatic islet cells.
    Hultcrantz M; Hühn MH; Wolf M; Olsson A; Jacobson S; Williams BR; Korsgren O; Flodström-Tullberg M
    Virology; 2007 Oct; 367(1):92-101. PubMed ID: 17559902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coxsackieviruses and diabetes.
    Ramsingh AI; Chapman N; Tracy S
    Bioessays; 1997 Sep; 19(9):793-800. PubMed ID: 9297970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coxsackievirus infection as an environmental factor in the etiology of type 1 diabetes.
    Richer MJ; Horwitz MS
    Autoimmun Rev; 2009 Jun; 8(7):611-5. PubMed ID: 19393207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coxsackievirus B Vaccines Prevent Infection-Accelerated Diabetes in NOD Mice and Have No Disease-Inducing Effect.
    Stone VM; Butrym M; Hankaniemi MM; Sioofy-Khojine AB; Hytönen VP; Hyöty H; Flodström-Tullberg M
    Diabetes; 2021 Dec; 70(12):2871-2878. PubMed ID: 34497136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal environment affects endogenous virus induction in the offspring of type 1 diabetes model non-obese diabetic mice.
    Kagohashi Y; Udagawa J; Moriyama K; Otani H
    Congenit Anom (Kyoto); 2005 Sep; 45(3):80-4. PubMed ID: 16131364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.